Invention Grant
- Patent Title: Oligonucleotides for modulating target RNA activity
- Patent Title (中): 用于调节靶RNA活性的寡核苷酸
-
Application No.: US12664502Application Date: 2008-06-13
-
Publication No.: US08691965B2Publication Date: 2014-04-08
- Inventor: Thorleif Møller
- Applicant: Thorleif Møller
- Applicant Address: DK Kongens Lyngby
- Assignee: Mirx Therapeutics Aps
- Current Assignee: Mirx Therapeutics Aps
- Current Assignee Address: DK Kongens Lyngby
- Agency: Foley & Lardner LLP
- Priority: DK200700860 20070614; DK200701493 20071016; DK200701504 20071018; DK200701580 20071109; DK200701725 20071203; DK200800214 20080215
- International Application: PCT/DK2008/050141 WO 20080613
- International Announcement: WO2008/151639 WO 20081218
- Main IPC: C07H21/04
- IPC: C07H21/04 ; C12Q1/68

Abstract:
The present invention relates to oligonucleotides for modulation of target RNA activity. Thus, the invention provides oligonucleotides that bind to microRNA binding sites of target RNA. The oligonucleotides may activate RNase H or RNAi. In a preferred embodiment, the oligonucleotides prevents a microRNA from binding to its binding site of the target RNA and thereby prevent the microRNA from regulating the target RNA. Such oligonucleotides have uses in research and development of new therapeutics.
Public/Granted literature
- US20100256223A1 OLIGONUCLEOTIDES FOR MODULATING TARGET RNA ACTIVITY Public/Granted day:2010-10-07
Information query